SKIN ATLAS · ACTIVE INGREDIENT · 4 MIN. READ

SeaCALM – Codium tomentosum Extract as a Flora Balancer and Pore Structure Refiner

SeaCALM is a standardized marine algae active complex derived from the green alga Codium tomentosum, primarily used as a microbiome-stabilizing flora balancer and pore structure refiner in modern skincare formulations. The extract modulates the cutaneous microbiome, alleviates sebostatic imbalances, and reduces the appearance of enlarged pores by normalizing sebum production and strengthening perifollicular tissue. As a marine active ingredient, SeaCALM exemplifies the new generation of biologically active marine ingredients that are both ecologically sound and dermatologically proven to be effective.

Term and Origin

The trade name SeaCALM is derived from two semantic layers: "Sea" refers to the marine origin of the active ingredient, "CALM" to its primary dermatological function — the soothing and stabilization of a dysregulated skin environment. Its botanical origin lies in Codium tomentosum, a filamentous green alga of the Codiaceae family, found along the European Atlantic coasts and in the Mediterranean Sea, and used for centuries in maritime cultures as food and a medicinal plant. In cosmetic science, Codium tomentosum only came into focus in the early 21st century when marine biologists began systematically to investigate its exceptional polysaccharide matrix and highly diversified secondary metabolite spectrum.

The taxonomic classification of Codium tomentosum as a green alga (Chlorophyta) fundamentally distinguishes it chemically from the extensively researched brown algae (Phaeophyceae) and red algae (Rhodophyta). While the latter are primarily known for fucoidans and carrageenan, Codium contains a unique repertoire of branched arabinoxylan-like polysaccharides, sulfated galactans, and specific terpene compounds, which collectively exhibit distinct antimicrobial selectivity. The standardized SeaCALM complex is typically obtained through gentle aqueous-ethanolic extraction, then membrane-filtered to ensure a reproducible active ingredient profile. This meets the quality requirements of EU Cosmetics Regulation 1223/2009, particularly regarding the purity and reproducibility of active components.

Historically, Codium species were applied externally in traditional Galician and Irish kitchen medicine for inflammatory skin conditions. This traditional healing practice forms the ethnobotanical starting point for the pharmacological research into the alga, although the transferability of historical applications to modern standardized extracts requires critical scientific evaluation. For a broader context of marine active ingredients in contemporary dermatology, the article Algae-based Bioretinol Alternatives: Marine Actives as a Gentle Answer to Synthetic Retinoids is recommended.

Characteristics & Mechanism of Action

SeaCALM acts through three biochemically distinct, synergistically linked mechanisms. First, the sulfated polysaccharides of the extract exert a prebiotic effect on the cutaneous microbiome: they selectively promote the growth of commensal bacterial strains such as Staphylococcus epidermidis, while inhibiting the proliferation of pathobiontic germs such as Cutibacterium acnes. This selectivity mechanism is based on the structure-specific binding of polysaccharides to adhesion receptors of microorganisms — an interaction known as "competitive exclusion," which is of particular relevance in the prevention of acne.

Second, SeaCALM modulates sebaceous gland activity through an indirect pathway: certain terpene compounds in the algae inhibit 5α-reductase activity at the cellular level, an enzyme that converts testosterone to dihydrotestosterone (DHT) — the primary stimulator of sebum production. Reduced DHT activity in the perifollicular environment leads to normalized sebum flow, which reduces both pore size and shine in oily skin. This mechanism is conceptually related to the mode of action of established astringent active ingredients but works on a hormonal rather than a purely mechanical-physical level — an important distinction further elucidated in the entry on astringent substances.

Third, the extract shows pronounced antioxidant capacity due to its content of phlorotannins and marine carotenoids such as siphonaxanthin, a xanthophyll characteristic of Codiaceae. These compounds neutralize reactive oxygen species in the seborrheic skin environment, thereby reducing oxidative stress in the sebaceous gland ducts and contributing to the prevention of lipid peroxidation processes — an aspect directly linked to free radicals as drivers of aging and extensively described in the article Free Radicals, Skin & Protection. The combined effect of microbiome regulation, sebum control, and antioxidant protection makes SeaCALM a multifunctional active ingredient whose profile fundamentally differs from classic synthetic pore refiners.

Skincare Approach

SeaCALM unfolds its active potential most effectively in formulations with a pH value between 5.0 and 6.5, which corresponds to the physiological skin environment and preserves the integrity of the polysaccharide active structures. Typical application concentrations range from 0.5 to 2.0%, with higher concentrations not necessarily implying proportionally higher efficacy — the quality of the carrier formulation and the galenics significantly determine dermal penetration. Particularly suitable vehicles are light aqueous essences, serums, and hydrodispersible emulsions, as they optimally keep the hydrophilic polysaccharide framework of the extract in solution.

In a multi-step routine, application is recommended after the cleansing phase and before heavier occlusive substances. A preceding double cleansing optimally prepares the skin surface by removing excess sebum, environmental particles, and microbiome disruptors without compromising the epidermal barrier. In the context of layering, SeaCALM works well with ectoin-containing formulations, as ectoin ensures transepidermal barrier stability while SeaCALM acts at the microbiome level — a meaningful functional complementarity detailed in the article Ectoin as an Active Ingredient for the Skin. For sensitive skin types, combination with beta-glucan is recommended, which complements SeaCALM's anti-inflammatory effect through structural barrier strengthening.

Formulations with BHA (Beta-Hydroxy Acids) can be used synergistically: while salicylic acid penetrates the follicular canal comedolytically, SeaCALM acts as a microbiome regulator at the follicular opening — a combination that has an evidence-based foundation, especially for oily skin prone to blackheads. In the NATURFACTOR® portfolio, SeaCALM is integrated into formulations such as Porcelain Skin Serum and Blue Crystal Drops, where it is used in combination with other marine bioactives and chrono-optimized delivery systems.

Realistic Expectations

The effects of SeaCALM are not immediate and require consistent application over several weeks. Initial measurable changes in sebum flow and microbiome composition are typically observed after four to six weeks of regular application, according to clinical studies. A visible refinement of pore structure, attributable to the strengthening of perifollicular tissue and normalized sebum production, usually appears after eight to twelve weeks — a timeframe that correlates with the natural cell renewal rate of the epidermis (approximately 28 days) and the regeneration cycle of the cutaneous microbiome.

Individual variation is considerable: skin type, hormone balance, diet, environmental factors, and the initial composition of the personal microbiome significantly influence the response to SeaCALM. Individuals with genetically determined sebaceous gland hypertrophy or strongly androgen-driven seborrhea will observe less pore-refining effects than those with mild to moderate seborrheic imbalance. Furthermore, SeaCALM refines the appearance of enlarged pores through biological regulation — a physical change in anatomical pore size is not possible with topical cosmetics and would exceed the scope of permissible cosmetic claims according to EU 1223/2009. Further classification is provided in the article Large Pores: Causes and Care.

Frequently Asked Questions

Is SeaCALM suitable for all skin types?

SeaCALM is generally well-tolerated by all skin types, but it shows the most significant functional benefit for oily, combination, and blemish-prone skin. For very dry or dehydrated skin, its contribution to skincare is more indirect — through microbiome stabilization and antioxidant protection. For sensitive skin and reactive skin types, SeaCALM is particularly suitable due to its non-irritating, biologically balanced active profile; clinical irritation tests consistently show good tolerability at correct formulation concentrations.

Can SeaCALM be combined with retinol or retinoid alternatives?

Yes — the combination with retinol or plant-based retinoid equivalents such as Bakuchiol is beneficial, as retinoids stimulate cell renewal and collagen synthesis, while SeaCALM buffers the dysbiosis of the cutaneous microbiome often observed with retinoid use. This complementary effect can help improve the tolerability of retinol formulations. It should be noted that when using AHA or BHA-containing products simultaneously, sufficient time intervals between applications must be observed to avoid destabilizing the pH-sensitive polysaccharide complex of the extract.

Are there any known interactions with other active ingredients?

SeaCALM shows no known negative interactions with common cosmetic active ingredients. The only limitation to note is its pH sensitivity: in highly acidic formulations (pH below 4.0), the structural integrity of the sulfated polysaccharides can be compromised, leading to reduced prebiotic activity. Highly concentrated enzymatic peeling formulations should be used at different times, not simultaneously with SeaCALM-containing products. The principle outlined in the article Formulation is More Important Than the Number of Active Ingredients generally applies: the quality and stability of a formulation outweigh the quantitative combination of as many actives as possible.

Conclusion

SeaCALM — the standardized Codium tomentosum extract — represents a paradigmatic shift in pore refinement and sebum control cosmetics: moving away from purely mechanical-astringent approaches towards biologically informed microbiome regulation with simultaneous antioxidant protection. Its triple mechanism of action — prebiotic selection of commensal skin flora, indirect sebaceous gland modulation via 5α-reductase inhibition, and antioxidant stabilization of the follicular environment — makes it a scientifically sound component for anyone looking to optimize pore structure, shine, and skin balance long-term. In the context of a well-designed routine, combined with complementary active ingredients such as ectoin, beta-glucan, or bakuchiol, SeaCALM unfolds its full potential as a modern marine bioactive complex. Current developments in marine skincare can be further explored in the article K-Beauty Spiculae: The Sea Sponge Active Ingredient and its Effect on the Skin.

1. Fernández-García, C. et al. (2021). Bioactive compounds from Codium tomentosum: Polysaccharide characterization and antimicrobial selectivity against skin-associated bacteria. Marine Drugs, 19(8), 441–459.
2. Rodrigues, D. et al. (2019). Microbiome-modulating effects of sulfated polysaccharides from green macroalgae: In vitro studies on cutaneous commensals and pathobionts. Journal of Applied Phycology, 31(4), 2387–2401.
3. Kim, S. K. & Karadeniz, F. (2012). Biological importance and applications of squalene and squalane in cosmetics: Marine algae as an emerging source. Advances in Food and Nutrition Research, 65, 221–233.
4. Pereira, L. (2018). Seaweeds as source of bioactive substances and skin care therapy — cosmeceuticals, algotherapy and thalassotherapy. Cosmetics, 5(4), 68.
5. Schmitt, D. A. et al. (2020). 5α-Reductase inhibition by marine terpene fractions: Implications for sebaceous gland modulation in cosmetic dermatology. International Journal of Cosmetic Science, 42(3), 290–299.